Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00094159 · ClinicalTrials.gov registry record · Phase 1
Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors
A Phase 1 study, sponsored by Sunesis Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00094159 is a Phase 1 study that has completed, run by Sunesis Pharmaceuticals.
The verdict
NCT00094159, a Phase 1 study, has completed, sponsored by Sunesis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to determine whether SNS-595 given intravenously weekly for 3 weeks is safe.
Interventions
- DRUG SNS-595
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00094159
The ClinicalTrials.gov registry entry for NCT00094159 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Sunesis Pharmaceuticals, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SNS-595 is the first listed.
NCT00094159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00094159 about?
NCT00094159 is a clinical study titled "Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors". The purpose of this study is to determine whether SNS-595 given intravenously weekly for 3 weeks is safe.
What is the current status of trial NCT00094159?
This trial is currently completed. It is a Phase 1 study. The study started on 2004-10.
What interventions are being tested in trial NCT00094159?
The interventions under investigation include: SNS-595 (DRUG).
Who is sponsoring clinical trial NCT00094159?
This trial is sponsored by Sunesis Pharmaceuticals, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.